Filing Flows › Beam Therapeutics (BEAM) › Recalls, complaints & regulation
Beam Therapeutics (BEAM): clinical trials
Beam Therapeutics (BEAM) beyond its filings: 7 active clinical trials.
Beam Therapeutics' latest quarter
Beam Therapeutics, Q3 2026: revenue $307K (-97% year over year), net loss $134M, operating cash flow −$111M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Beam Therapeutics have?
7 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.